Search

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

Trial Phase 2 Completed Sept. 28, 2010

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

Trial Phase 3 Completed Sept. 12, 2010

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

Trial Phase 4 Completed Sept. 7, 2010

Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease

Trial Phase 3 Completed Aug. 23, 2010

Levodopa Concentration Profile With Stalevo 75/125 mg

Trial Phase 1 Completed Aug. 12, 2010

Glutathione (GSH) In The Treatment of Parkinson's Disease

Trial Phase 2 Completed Aug. 8, 2010

A Trial of MitoQ for the Treatment of People With Parkinson's Disease

Trial Phase 2 Completed July 20, 2010

Parkinson's Disease Registry of the Muhammad Ali Parkinson Center

Trial N/A Unknown July 20, 2010

Antidepressant Effect of Deep Brain Stimulation in Parkinson's Disease Patients

Trial N/A Completed June 2, 2010

Clinical Trial on the Effectiveness of Traditional Chinese Medicinal Mixture in Parkinson Disease

Trial Phase 2 Unknown May 27, 2010

Effects of Chocolate on Motor Symptoms of Parkinson's Disease

Trial N/A Unknown May 25, 2010

A Pilot, Randomized Controlled Trial of Group Visits for Persons With Parkinson's Disease

Trial N/A Completed May 24, 2010

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa

Trial Phase 2 Completed May 13, 2010

COMT Polymorphism and Entacapone Efficacy

Trial Phase 4 Completed April 28, 2010

Rasagiline for Gait Treatment

Trial N/A Unknown April 1, 2010

SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease

Trial N/A Completed March 30, 2010

Italian Validation of the Revised MDS-Unified Parkinson's Disease Rating Scale

Trial N/A Unknown March 24, 2010

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients' First Degree Relatives

Trial N/A Unknown March 17, 2010

Ioflupane I123 (DaTSCAN) and Positron Emission Tomography-computed Tomography Fludeoxyglucose (PET-CT FDG) to Assess Brain Function of Parkinson Patients With Different Genetic Characteristics

Trial N/A Unknown March 17, 2010

Effectiveness of Physiotherapy Interventions for Patients With Parkinson's Disease

Trial N/A Unknown March 9, 2010